ABN Amro has won its second multi-billion flotation mandate in less than a week, after it was picked to launch the initial public offering of a Dutch pharmaceuticals company.
The Netherlands-based bank been hired to work on the €9bn ($11.5bn) spinoff and listing of chemicals group Akzo Nobel's pharmaceutical business.
